1. Home
  2. LIXT vs JVA Comparison

LIXT vs JVA Comparison

Compare LIXT & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.99

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.59

Market Cap

21.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
JVA
Founded
2005
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
21.0M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
LIXT
JVA
Price
$3.99
$3.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
90.8K
37.5K
Earning Date
11-12-2025
01-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
64.91
EPS
N/A
0.32
Revenue
N/A
$89,748,681.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.87
Revenue Growth
N/A
17.92
52 Week Low
$0.64
$2.75
52 Week High
$6.26
$9.93

Technical Indicators

Market Signals
Indicator
LIXT
JVA
Relative Strength Index (RSI) 42.98 43.71
Support Level $4.01 $3.31
Resistance Level $4.40 $3.73
Average True Range (ATR) 0.31 0.17
MACD -0.01 0.02
Stochastic Oscillator 22.34 47.17

Price Performance

Historical Comparison
LIXT
JVA

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: